State Street’s Prelude Therapeutics PRLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $79K | Sell |
97,592
-188,454
| -66% | -$153K | ﹤0.01% | 4017 |
|
|
2025
Q1 | $220K | Sell |
286,046
-7,350
| -3% | -$5.65K | ﹤0.01% | 3798 |
|
|
2024
Q4 | $374K | Buy |
293,396
+7,350
| +3% | +$9.37K | ﹤0.01% | 3698 |
|
|
2024
Q3 | $592K | Buy |
286,046
+74,300
| +35% | +$154K | ﹤0.01% | 3566 |
|
|
2024
Q2 | $807K | Buy |
211,746
+305
| +0.1% | +$1.16K | ﹤0.01% | 3498 |
|
|
2024
Q1 | $1M | Sell |
211,441
-793
| -0.4% | -$3.76K | ﹤0.01% | 3473 |
|
|
2023
Q4 | $906K | Buy |
212,234
+25,025
| +13% | +$107K | ﹤0.01% | 3499 |
|
|
2023
Q3 | $578K | Buy |
187,209
+3,400
| +2% | +$10.5K | ﹤0.01% | 3635 |
|
|
2023
Q2 | $827K | Buy |
183,809
+139,920
| +319% | +$630K | ﹤0.01% | 3611 |
|
|
2023
Q1 | $250K | Hold |
43,889
| – | – | ﹤0.01% | 3983 |
|
|
2022
Q4 | $265K | Hold |
43,889
| – | – | ﹤0.01% | 4004 |
|
|
2022
Q3 | $290K | Hold |
43,889
| – | – | ﹤0.01% | 3978 |
|
|
2022
Q2 | $229K | Sell |
43,889
-165,972
| -79% | -$866K | ﹤0.01% | 4134 |
|
|
2022
Q1 | $1.45M | Buy |
209,861
+1,455
| +0.7% | +$10K | ﹤0.01% | 3680 |
|
|
2021
Q4 | $2.6M | Sell |
208,406
-642,077
| -75% | -$7.99M | ﹤0.01% | 3559 |
|
|
2021
Q3 | $26.6M | Sell |
850,483
-201,733
| -19% | -$6.3M | ﹤0.01% | 2273 |
|
|
2021
Q2 | $30.1M | Buy |
1,052,216
+178,840
| +20% | +$5.12M | ﹤0.01% | 2223 |
|
|
2021
Q1 | $37.8M | Buy |
873,376
+731,043
| +514% | +$31.7M | ﹤0.01% | 1949 |
|
|
2020
Q4 | $10.2M | Buy |
+142,333
| New | +$10.2M | ﹤0.01% | 2621 |
|